Low/Intermediate PCa Video Chat, Feb 10, 2025

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:

Men (Only) Speaking Freely…1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
Veterans Healthcare Navigation… 1st & 3rd Tuesdays @ 8.00 pm Eastern https://ancan.org/veterans/

AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.

AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.

AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download

AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.

All AnCan’s groups are free and drop-in … join us in person sometime!

You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/
Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Editor’s Pick: Trust but verify a biopsy reading. Getting a second opinion is critical for choosing the correct treatment option for yourself. (bj)

Topics Discussed
Weak stream; enlarged prostate — presumptive BPH; TURP; greenlight laser; DECIPHER; DECIPHER Grid Report; germline genetic test; PROMISE Test; gradually rising PSA; TULSA Procedure; CyberKnife; NCCN (National Comprehensive Cancer Network); PROSTOX genetic test; combination therapy; PSMA PET Scan make sure your insurance will pay for it first.

Chat Log

AnCan – rick
BPH webinar – Steve Kaplan https://ancan.org/special-presentation-it-aint-your-grandpas-bph/

Jim Marshall, Alexandria, VA
If there are Veterans in the group, there is a Veterans Group meeting 1st & 3rd Tuesdays. contact me for details, Veterans@AnCan.Org info at www.AnCan.org/Veterans Jim Marshall, USAF(Ret)

John S NY
Dutasteride is generally more potent and effective than finasteride for treating hair loss and BPH. However, it may also have a slightly higher risk of side effects. The choice between the two medications should be made in consultation with a healthcare professional based on individual factors such as the severity of hair loss or BPH symptoms, potential side effects, and halflife of Dutasteride is 40 days, Finasteride is around 12-18 hours if I remember correctly

AnCan – rick
PROMISE test https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar

Eric M- Atlanta
Dr. Epstein is back in biz this month consulting with Integrated Medical Professionals in NYC. Reach him through gdeliquori@imppllc

Michael – TN
gdeliquori@imppllc – Dr Epstein

Eric M- Atlanta
Dr. Ming Zhou, can be found at ming.zhou@mountsinai.org

Eric M- Atlanta
As I say, Trust but verify a biopsy reading.

AnCan – rick
gdeliguori@imppllc.com• Epstein

Eric M- Atlanta
If anyone wants to get their own PSA test with Labcorp here is a self ordered source for $31: https://www.lifeextension.com/lab-testing/itemlc010322/prostate-specific-antigen-psa-blood-test

David S.
Jesse McKenney interview on the topic of cribriform: https://www.urotoday.com/video-lectures/a-journal-club-for-patients-with-prostate-cancer/video/4452-unfavorable-histology-classification-aims-to-reduce-unnecessary-treatment-journal-club-jesse-mckenney-jane-nguyen-cornelia-ding.html

AnCan – rick
Here’s the NIH 2nd opinion clinic for PCa link https://ccr.cancer.gov/prostate-cancer-multidisciplinary-clinic

Michael – TN
Choyke, Peter (NIH/NCI) [E] <pchoyke@mail.nih.gov>

Low/Intermediate PCa Video Chat, Feb 10, 2025